GlassScriptPhysician profile
Drew Michael S Donnell
NPI 1447711866
$13,669.20
in general payments reported to CMS, 2019-2025
11 companies · $7,137 in 2025
The $7,137 reported for 2025 was more than what 94% of Pain Medicine providers received nationally (typical 2025 total: $515).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $3,145 · 2024: $3,387 · 2025: $7,137.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,166 · Travel and Lodging: $4,736 · Education: $767.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,166.26 |
| Travel and Lodging | $4,736.02 |
| Education | $766.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $5,943.23 | 2023-2025 | General - Therapies, Vercise, General - Pain Management |
| Medtronic, INC. | $3,841.34 | 2024-2025 | Intellis Adaptivestim, Synchromedii, Accurian |
| Nevro Corp. | $1,202.99 | 2023 | Omnia, Senza |
| Abbott Laboratories | $1,143.19 | 2023-2025 | Proclaim, Eterna |
| Spr Therapeutics, INC | $752.22 | 2023-2025 | Sprint Pns System |
| Saluda Medical Americas, INC. | $377.23 | 2023-2024 | Evoke, Evoke Scs |
| Biotronik Nro, INC. | $168.96 | 2024 | Prospera |
| Abbvie INC. | $136.76 | 2023-2024 | Botox |
| Stryker Corporation | $39.71 | 2025 | Mild Device Kit |
| Vertex Pharmaceuticals Incorporated | $39.46 | 2025 | |
| Avanos Medical | $24.11 | 2024 | Coolief* Cooled Radiofrequency |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Drew Michael Donnell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.